vs

Side-by-side financial comparison of NeuroPace Inc (NPCE) and PARKE BANCORP, INC. (PKBK). Click either name above to swap in a different company.

NeuroPace Inc is the larger business by last-quarter revenue ($26.6M vs $22.7M, roughly 1.2× PARKE BANCORP, INC.). PARKE BANCORP, INC. runs the higher net margin — 48.8% vs -10.3%, a 59.0% gap on every dollar of revenue. On growth, PARKE BANCORP, INC. posted the faster year-over-year revenue change (35.7% vs 23.9%). PARKE BANCORP, INC. produced more free cash flow last quarter ($39.0M vs $409.0K). Over the past eight quarters, PARKE BANCORP, INC.'s revenue compounded faster (22.6% CAGR vs 21.1%).

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

Parke Bancorp, Inc. is a U.S. regional bank holding company operating Parke Bank. It offers commercial and retail banking services including deposit products, mortgage loans, small business financing and personal lending, primarily serving customers across New Jersey and the Philadelphia metropolitan area.

NPCE vs PKBK — Head-to-Head

Bigger by revenue
NPCE
NPCE
1.2× larger
NPCE
$26.6M
$22.7M
PKBK
Growing faster (revenue YoY)
PKBK
PKBK
+11.8% gap
PKBK
35.7%
23.9%
NPCE
Higher net margin
PKBK
PKBK
59.0% more per $
PKBK
48.8%
-10.3%
NPCE
More free cash flow
PKBK
PKBK
$38.5M more FCF
PKBK
$39.0M
$409.0K
NPCE
Faster 2-yr revenue CAGR
PKBK
PKBK
Annualised
PKBK
22.6%
21.1%
NPCE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPCE
NPCE
PKBK
PKBK
Revenue
$26.6M
$22.7M
Net Profit
$-2.7M
$11.1M
Gross Margin
77.4%
Operating Margin
-6.6%
64.2%
Net Margin
-10.3%
48.8%
Revenue YoY
23.9%
35.7%
Net Profit YoY
48.0%
49.8%
EPS (diluted)
$-0.08
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPCE
NPCE
PKBK
PKBK
Q4 25
$26.6M
$22.7M
Q3 25
$27.4M
$21.0M
Q2 25
$23.5M
$18.7M
Q1 25
$22.5M
$17.4M
Q4 24
$21.5M
$16.8M
Q3 24
$21.1M
$15.6M
Q2 24
$19.3M
$15.5M
Q1 24
$18.1M
$15.1M
Net Profit
NPCE
NPCE
PKBK
PKBK
Q4 25
$-2.7M
$11.1M
Q3 25
$-3.5M
$10.6M
Q2 25
$-8.7M
$8.3M
Q1 25
$-6.6M
$7.8M
Q4 24
$-5.3M
$7.4M
Q3 24
$-5.5M
$7.5M
Q2 24
$-7.5M
$6.5M
Q1 24
$-8.9M
$6.2M
Gross Margin
NPCE
NPCE
PKBK
PKBK
Q4 25
77.4%
Q3 25
77.4%
Q2 25
77.1%
Q1 25
77.0%
Q4 24
75.4%
Q3 24
73.2%
Q2 24
73.4%
Q1 24
73.6%
Operating Margin
NPCE
NPCE
PKBK
PKBK
Q4 25
-6.6%
64.2%
Q3 25
-9.5%
64.2%
Q2 25
-29.0%
59.0%
Q1 25
-22.9%
59.1%
Q4 24
-17.0%
58.0%
Q3 24
-20.1%
60.2%
Q2 24
-32.4%
56.7%
Q1 24
-41.6%
55.4%
Net Margin
NPCE
NPCE
PKBK
PKBK
Q4 25
-10.3%
48.8%
Q3 25
-12.8%
50.6%
Q2 25
-36.8%
44.3%
Q1 25
-29.3%
44.6%
Q4 24
-24.5%
44.2%
Q3 24
-25.9%
48.1%
Q2 24
-39.0%
41.6%
Q1 24
-49.2%
40.7%
EPS (diluted)
NPCE
NPCE
PKBK
PKBK
Q4 25
$-0.08
$0.93
Q3 25
$-0.11
$0.89
Q2 25
$-0.26
$0.69
Q1 25
$-0.21
$0.65
Q4 24
$-0.16
$0.61
Q3 24
$-0.19
$0.62
Q2 24
$-0.26
$0.53
Q1 24
$-0.32
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPCE
NPCE
PKBK
PKBK
Cash + ST InvestmentsLiquidity on hand
$61.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$19.0M
$324.5M
Total Assets
$105.6M
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPCE
NPCE
PKBK
PKBK
Q4 25
$61.1M
Q3 25
$60.0M
Q2 25
$62.1M
Q1 25
$66.3M
Q4 24
$52.8M
Q3 24
$56.8M
Q2 24
$55.5M
Q1 24
$58.9M
Stockholders' Equity
NPCE
NPCE
PKBK
PKBK
Q4 25
$19.0M
$324.5M
Q3 25
$18.5M
$314.8M
Q2 25
$19.4M
$312.2M
Q1 25
$24.3M
$305.9M
Q4 24
$8.0M
$300.1M
Q3 24
$9.8M
$296.5M
Q2 24
$9.9M
$292.8M
Q1 24
$14.3M
$288.4M
Total Assets
NPCE
NPCE
PKBK
PKBK
Q4 25
$105.6M
$2.2B
Q3 25
$107.3M
$2.2B
Q2 25
$106.1M
$2.2B
Q1 25
$110.2M
$2.1B
Q4 24
$94.6M
$2.1B
Q3 24
$96.3M
$2.1B
Q2 24
$94.4M
$2.0B
Q1 24
$98.9M
$2.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPCE
NPCE
PKBK
PKBK
Operating Cash FlowLast quarter
$506.0K
$39.6M
Free Cash FlowOCF − Capex
$409.0K
$39.0M
FCF MarginFCF / Revenue
1.5%
171.3%
Capex IntensityCapex / Revenue
0.4%
2.6%
Cash ConversionOCF / Net Profit
3.57×
TTM Free Cash FlowTrailing 4 quarters
$-11.3M
$63.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPCE
NPCE
PKBK
PKBK
Q4 25
$506.0K
$39.6M
Q3 25
$-1.9M
$11.4M
Q2 25
$-2.1M
$6.8M
Q1 25
$-7.5M
$7.0M
Q4 24
$-4.8M
$35.2M
Q3 24
$-1.7M
$9.4M
Q2 24
$-3.9M
$8.9M
Q1 24
$-7.5M
$8.3M
Free Cash Flow
NPCE
NPCE
PKBK
PKBK
Q4 25
$409.0K
$39.0M
Q3 25
$-2.0M
$11.2M
Q2 25
$-2.3M
$6.7M
Q1 25
$-7.5M
$6.6M
Q4 24
$-4.8M
$35.0M
Q3 24
$-1.8M
$9.4M
Q2 24
$-4.0M
$8.9M
Q1 24
$-7.6M
$8.3M
FCF Margin
NPCE
NPCE
PKBK
PKBK
Q4 25
1.5%
171.3%
Q3 25
-7.2%
53.5%
Q2 25
-9.6%
35.8%
Q1 25
-33.4%
38.0%
Q4 24
-22.5%
209.1%
Q3 24
-8.7%
60.0%
Q2 24
-20.6%
57.1%
Q1 24
-42.1%
55.1%
Capex Intensity
NPCE
NPCE
PKBK
PKBK
Q4 25
0.4%
2.6%
Q3 25
0.1%
0.5%
Q2 25
0.7%
0.3%
Q1 25
0.2%
2.2%
Q4 24
0.2%
0.7%
Q3 24
0.5%
0.1%
Q2 24
0.3%
0.2%
Q1 24
0.6%
0.1%
Cash Conversion
NPCE
NPCE
PKBK
PKBK
Q4 25
3.57×
Q3 25
1.07×
Q2 25
0.82×
Q1 25
0.90×
Q4 24
4.75×
Q3 24
1.25×
Q2 24
1.38×
Q1 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons